“Secukinumab’s Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment”, J of Skin, vol. 2, no. S1, p. S18, Feb. 2018, doi: 10.25251/skin.2.supp.18.